Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Mersana on Friday said the new designation covers the drug, XMT-1660, for the treatment of advanced or metastatic breast cancer in patients with human epidermal growth factor receptor 2 low or ...

New breast cancer drug given green light for NHS use - Breast Cancer Now said olaparib will be an ‘valuable alternative’ for ...

Around 1,200 people with advanced breast cancer could benefit from a decision by NICE to give the go-ahead to a new treatment ...

Tumor cells circulating in the blood are the germ cells of breast cancer metastases. They are very rare and have not been ...

Incredible” results from the PATINA trial suggested a new standard of care for HER2, ER-positive metastatic breast cancer.

The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response ...

When Kristen Dahlgren left journalism to launch a cancer vaccine initiative, she never imagined it would reconnect her with ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

This page includes links to articles highlighting the top breast cancer research published on Cancer Therapy Advisor in 2024.

New University of Cincinnati Cancer Center research has identified a particular strand of microRNA as a promising new target ...

It’s a diagnosis more than two million women worldwide receive every year: breast cancer.It also accounts for about 30% of all new female cancers each year.On Tuesday night, ABC 6 News anchor Robin ...